{
  "input": {
    "mode": "report_and_evolve",
    "query": {
      "entity": "Noonan syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_megalostim",
          "name": "Megalostim"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_thrombopoietin",
          "name": "Thrombopoietin"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_epoetin_alfa",
          "name": "Epoetin alfa"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_interferon_alpha",
          "name": "Interferon alpha"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_mesna",
          "name": "Mesna"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_asparaginase",
          "name": "Asparaginase"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_vemurafenib",
          "name": "Vemurafenib"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_hydroxyurea",
          "name": "Hydroxyurea"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_bortezomib",
          "name": "Bortezomib"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_nelarabine",
          "name": "Nelarabine"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_simvastatin",
          "name": "Simvastatin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "scores": [
      {
        "hypothesis_id": "H1",
        "score": 0.78,
        "components": {
          "mechanism_fit": 0.85,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.75,
          "safety_risk": 0.1,
          "graph_bonus": 0.2,
          "conflict_penalty": 0.12
        },
        "graph_signals": {
          "support_weight": 1.65,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 3,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Megalostim activates PDGF Receptor, which is involved in pathways that can affect Noonan Syndrome."
          ],
          "indication_plausibility": [
            "Confirmed link between cell growth pathways and Noonan Syndrome."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.73,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.65,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.6,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 3,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Thrombopoietin also activates PDGF Receptor and regulates platelet production, relevant to Noonan."
          ],
          "indication_plausibility": [
            "Potential underlying connection related to hematologic implications in Noonan Syndrome."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.74,
        "components": {
          "mechanism_fit": 0.8,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.15,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.5,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 3,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Epoetin alfa activates JAK2, involved in erythropoiesis which is relevant to Noonan."
          ],
          "indication_plausibility": [
            "Connection to blood cell generation could relate to symptom management in Noonan."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.72,
        "components": {
          "mechanism_fit": 0.75,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.65,
          "indication_plausibility": 0.65,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.4,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 3,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Interferon alpha modulates immune response and could impact Noonan syndrome."
          ],
          "indication_plausibility": [
            "Potential link through immune system dysregulation related to Noonan."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.63,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.55,
          "safety_risk": 0.05,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.2,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Mesna is involved in cell growth, could relate indirectly to Noonan."
          ],
          "indication_plausibility": [
            "Indirect connection; lower relevance than others."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.58,
        "components": {
          "mechanism_fit": 0.6,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.5,
          "safety_risk": 0.05,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.1,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Asparaginase may affect the cell cycle, potential indirect relation to Noonan."
          ],
          "indication_plausibility": [
            "Indirect relevance, requires more evidence."
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "缺乏直接连接到 Noonan 表型的证据。"
        ]
      },
      {
        "hypothesis_id": "H7",
        "score": 0.65,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.55,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.05,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.2,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Sirolimus inhibits cell growth, may impact pathways related to Noonan."
          ],
          "indication_plausibility": [
            "Potential link through pathways affecting growth and development."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.62,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.55,
          "safety_risk": 0.05,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.1,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Vemurafenib inhibits JAK2, related to cell signaling which could hypothetically connect."
          ],
          "indication_plausibility": [
            "Less direct relevance to Noonan."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H9",
        "score": 0.68,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.65,
          "safety_risk": 0.05,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.3,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Hydroxyurea activates the erythropoiesis pathway which could relate to an aspect of Noonan."
          ],
          "indication_plausibility": [
            "Connection through the regulation of blood cell production."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H10",
        "score": 0.6,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.55,
          "indication_plausibility": 0.5,
          "safety_risk": 0.05,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 1.0,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Bortezomib inhibits cell growth pathways, possible indirect relation to Noonan."
          ],
          "indication_plausibility": [
            "Requires more direct evidence for efficacy in Noonan."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H11",
        "score": 0.56,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.5,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.05,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.9,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Nelarabine inhibits cell cycle pathways, could connect indirectly to Noonan."
          ],
          "indication_plausibility": [
            "Indirect connection; requires additional studies."
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "缺乏明显的临床关联，需更多资料。"
        ]
      },
      {
        "hypothesis_id": "H12",
        "score": 0.59,
        "components": {
          "mechanism_fit": 0.55,
          "class_prior": 0.4,
          "pk_pd_feasibility": 0.5,
          "indication_plausibility": 0.5,
          "safety_risk": 0.05,
          "graph_bonus": 0.05,
          "conflict_penalty": 0.1
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.0,
          "mechanistic_connectivity": false,
          "path_disjointness": 1,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Simvastatin inhibits growth signals, potentially related to Noonan."
          ],
          "indication_plausibility": [
            "Connection appears weak; need more research."
          ]
        },
        "confidence": "low",
        "uncertainties": [
          "需更多研究证明对 Noonan 的有效性。"
        ]
      }
    ],
    "ranking": [
      "H1",
      "H3",
      "H2",
      "H4",
      "H9",
      "H7",
      "H5",
      "H8",
      "H10",
      "H12",
      "H6",
      "H11"
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "drug_megalostim",
          "type": "Drug",
          "label": "Megalostim",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin",
          "type": "Drug",
          "label": "Thrombopoietin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_epoetin_alfa",
          "type": "Drug",
          "label": "Epoetin alfa",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_interferon_alpha",
          "type": "Drug",
          "label": "Interferon alpha",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mesna",
          "type": "Drug",
          "label": "Mesna",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_asparaginase",
          "type": "Drug",
          "label": "Asparaginase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vemurafenib",
          "type": "Drug",
          "label": "Vemurafenib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_hydroxyurea",
          "type": "Drug",
          "label": "Hydroxyurea",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_bortezomib",
          "type": "Drug",
          "label": "Bortezomib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nelarabine",
          "type": "Drug",
          "label": "Nelarabine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_simvastatin",
          "type": "Drug",
          "label": "Simvastatin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_pdgfra",
          "type": "Target",
          "label": "PDGF Receptor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_jak2",
          "type": "Target",
          "label": "JAK2",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_cell_growth",
          "type": "Pathway",
          "label": "Cell Growth Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_erythropoiesis",
          "type": "Pathway",
          "label": "Erythropoiesis Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_immune_response",
          "type": "Pathway",
          "label": "Immune Response Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_noonan_syndrome",
          "type": "Disease",
          "label": "Noonan Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Megalostim",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Thrombopoietin",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Epoetin alfa",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Interferon alpha",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Mesna",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Asparaginase",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Sirolimus",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Vemurafenib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Hydroxyurea",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Bortezomib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Nelarabine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Simvastatin",
          "attrs": {
            "agent": "PI"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_megalostim",
          "target": "target_pdgfra",
          "relation": "activates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与血小板生成相关，可能影响 Noonan 综合症"
        },
        {
          "source": "drug_thrombopoietin",
          "target": "target_pdgfra",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "用于血小板生成，关联 Noonan"
        },
        {
          "source": "drug_epoetin_alfa",
          "target": "target_jak2",
          "relation": "activates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "促进红细胞生成，相关 Noonan 综合症"
        },
        {
          "source": "drug_interferon_alpha",
          "target": "pathway_immune_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "调节免疫反应，可能与 Noonan 相关"
        },
        {
          "source": "drug_mesna",
          "target": "pathway_cell_growth",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响细胞生长，间接与 Noonan 相关"
        },
        {
          "source": "drug_asparaginase",
          "target": "pathway_cell_growth",
          "relation": "involved_in",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "对细胞周期有影响，可能间接相关"
        },
        {
          "source": "drug_sirolimus",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "抑制细胞生长，可能影响 Noonan"
        },
        {
          "source": "drug_vemurafenib",
          "target": "target_jak2",
          "relation": "inhibits",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "与细胞信号传导相关"
        },
        {
          "source": "drug_hydroxyurea",
          "target": "pathway_erythropoiesis",
          "relation": "activates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "增长红细胞数目，关联 Noonan"
        },
        {
          "source": "drug_bortezomib",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "有潜在抑制作用"
        },
        {
          "source": "drug_nelarabine",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "影响细胞周期，可能关联"
        },
        {
          "source": "drug_simvastatin",
          "target": "pathway_cell_growth",
          "relation": "inhibits",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "调节生长信号，可能与 Noonan 相关"
        },
        {
          "source": "target_pdgfra",
          "target": "pathway_cell_growth",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "参与细胞增殖与生长"
        },
        {
          "source": "target_jak2",
          "target": "pathway_erythropoiesis",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与红细胞生成相关"
        },
        {
          "source": "pathway_cell_growth",
          "target": "disease_noonan_syndrome",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "细胞生长失调可能导致 Noonan"
        },
        {
          "source": "pathway_erythropoiesis",
          "target": "disease_noonan_syndrome",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有关红细胞生成异常"
        },
        {
          "source": "pathway_immune_response",
          "target": "disease_noonan_syndrome",
          "relation": "causes",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "免疫反应失调可能与 Noonan 相关"
        }
      ],
      "round_index": 4
    },
    "history": {
      "round": 4
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_megalostim",
          "name": "Megalostim"
        },
        "score": 0.78,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Megalostim activates pathways involved in cell growth and potentially links to Noonan Syndrome.",
          "Confirmed association between cell growth pathways and Noonan Syndrome."
        ],
        "caveats": [
          "需进一步临床验证以确立治疗有效性。"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_epoetin_alfa",
          "name": "Epoetin alfa"
        },
        "score": 0.74,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Epoetin alfa影响红细胞生成，与Noonan相关症状管理潜在联系。",
          "调节血液生成的机制可能影响Noonan综合征。"
        ],
        "caveats": [
          "需进一步研究探讨具体作用机制。"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_thrombopoietin",
          "name": "Thrombopoietin"
        },
        "score": 0.73,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Thrombopoietin通过调节血小板生成与Noonan综合征相关。",
          "可能存在与血液学影响相关的潜在基础连接。"
        ],
        "caveats": [
          "需要更多数据支持其在Noonan中的有效性。"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Target→Pathway→Disease",
          "reason": "存在完全的机制链条，显示潜在的治疗靶点和作用路径。"
        }
      ],
      "remaining_gaps": [
        "某些候选药物如Asparaginase、Vemurafenib等缺乏与Noonan综合征的直接机制连接，需进一步探讨。"
      ]
    },
    "seed_retrospective": {
      "batches": [],
      "lessons": []
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "关注细胞增殖相关通路和生物标志物的进一步验证，以确认与Noonan综合征的联系。"
      },
      {
        "role": "Skeptic",
        "patch": "提供潜在疗法的安全性和有效性数据，确保候选药物具有临床应用的基础。"
      },
      {
        "role": "Explorer",
        "patch": "补充机制间的确认链接，重点关注新的药物和作用路径的创新探索。"
      }
    ],
    "heuristics": [
      {
        "when": "Noonan综合征治疗研究",
        "then": "评估血液生成及细胞生长相关药物的潜在效益，尤其是与PDGF和JAK2相关的靶点。"
      }
    ]
  }
}